articleOxford University Research Archive (ORA) (University of Oxford)Jan 1, 2020GREEN OA

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

FPFolegatti, PMEKEwer, KJRMRamasamy, MNMAMinassian, AMFAFlaxman, AL

University of Oxford · Jenner Institute · +6 more institutions

Abstract

No abstract available for this paper.

Citation impact

1,213
total citations
FWCI
29.29
Percentile
100%
References
25
Citations per year

Authors

51
  • FP
    Folegatti, PMCorresponding

    University of Oxford

  • EK
    Ewer, KJ

    University of Oxford, Jenner Institute

  • RM
    Ramasamy, MN

    University of Oxford, Jenner Institute

  • MA
    Minassian, AM

    University of Oxford, Jenner Institute

  • FA
    Flaxman, AL

    University of Oxford, Jenner Institute

Topics & keywords

Topics
Keywords
  • Medicine
  • Immunogenicity
  • Randomized controlled trial
  • Regimen
  • Vaccination
  • Clinical trial
  • Young adult
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding